How do you think the City of Memphis should use $3.2 million in tax revenue collected from AI data centers?

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

A single eye just became ground zero for one of science's biggest bets on turning back the clock on aging. Boston-based Life ...

The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first ...

Antonio Regalado —Will Douglas Heaven At SXSW London last week, I gave a talk called “Five things you need to know about AI,” ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

A 1948 psychology experiment explains why AI feels like it knows you. For children still forming an identity, that illusion ...

Biotech startup NewLimit secured a major funding round after claiming a scientific breakthrough of a prototype medicine that ...

A hot potato: Moderators of the /biohackers subreddit say they are dealing with spam that isn't just about pushing sales, but about shaping how AI systems answer questions. They say companies are ...

In this episode of DEMO, Keith Shaw speaks with Richard Robinson, Chief Evangelist at Unqork, about how the company's ...

NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells. After raising ...